Access cutting-edge chronic kidney disease treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access chronic kidney disease specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic kidney disease treatment provided free
The purpose of this study is to determine whether vonsetamig will safely decrease anti-HLA antibodies to allow for kidney transplantation. Vonsetamig is being studied for treatment of patients in need of kidney transplantation who are highly sensitized to HLA. The study is looking at several other research questions, including: * Side effects that may be experienced from taking vonsetamig * How vonsetamig works in the body * How much vonsetamig is present in the blood * If vonsetamig works to
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this chronic kidney disease clinical trial in Minneapolis, MN
If you're searching for chronic kidney disease treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.